Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus ...

The following is a summary of “Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world ...

According to one of the studies, GLP-1 receptor inhibitors, including semaglutide, dulaglutide, and liraglutide, marketed as Ozempic, Trulicity, and Victoza, respectively, were associated with a ...

A study published earlier this January, for instance, found some evidence that liraglutide (an older GLP-1 drug) could reduce the rate of brain shrinkage in people with Alzheimer’s (Gizmodo ...

dulaglutide and liraglutide, which are sold as Ozempic, Trulicity and Victoza, respectively — impacted dementia risk in people with type 2 diabetes. They also studied SGLT2 inhibitors like ...

The treatments, which include medications like semaglutide, liraglutide and exenatide, have been linked to a slightly reduced dementia risk before, but this was based on observational studies ...

The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. Zepbound is made by drugmaker Eli Lilly. While Hims & Hers ...

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP-1 agonists are used for weight loss in people ...

We’re committed to bringing our customers more treatment options that best suit their needs, and we’ve now expanded that choice even further by adding access to generic liraglutide and branded ...

Saxenda (liraglutide) and Ozempic (semaglutide) are brand-name solutions for subcutaneous injection. Saxenda is approved for weight management. Doctors may prescribe Ozempic off-label for this ...

Semaglutide-based medications, such as Ozempic and Rybelsus, and liraglutide-based medications, such as Victoza, are FDA approved to help manage blood sugar levels in people with type 2 diabetes.